MOBILON Trademark

Trademark Overview


On Monday, January 22, 2024, a trademark application was filed for MOBILON with the United States Patent and Trademark Office. The USPTO has given the MOBILON trademark a serial number of 98369340. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, August 21, 2024. This trademark is owned by Unipharm, Inc.. The MOBILON trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals and dietary supplements
mobilon

General Information


Serial Number98369340
Word MarkMOBILON
Filing DateMonday, January 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceuticals and dietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUnipharm, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10118

Trademark Events


Event DateEvent Description
Monday, January 22, 2024NEW APPLICATION ENTERED
Wednesday, May 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 21, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2024NON-FINAL ACTION WRITTEN
Friday, August 16, 2024ASSIGNED TO EXAMINER